MTOR and colorectal carcinoma: In addition, the PI3K/Akt/mTOR signaling pathway also contributes to carcinogenesis, CRC stem cell survival, increased morbidity, and decreased response to drugs in CRC pathogenesis (Ebrahimi et al. 2023).